Executive Director of TEVA, Andrew Westerkom, presented these talking points (click below) to the Health & Human Services committee as well as fielded questions from the committee.
Objective To review the available evidence regarding electronic cigarette (e-cigarette) product characterization and design features in order to understand their potential impact on individual users and on public health.
Methods Systematic literature searches in 10 reference databases were conducted through October 2013. A total of 14 articles and documents and 16 patents were included in this analysis.
Results Numerous disposable and reusable e-cigarette product options exist, representing wide variation in product configuration and component...
Objective To review the available literature evaluating electronic cigarette (e-cigarette) nicotine clinical pharmacology in order to understand the potential impact of e-cigarettes on individual users, nicotine dependence and public health.
Methods Literature searches were conducted between 1 October 2012 and 30 September 2013 using key terms in five electronic databases. Studies were included in the review if they were in English and publicly available; non-clinical studies, conference abstracts and studies exclusively measuring nicotine content...
Correspondence toDr Tianrong Cheng, Office of Science, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd, Rockville, MD 20850, USA; Tianrong.Cheng@fda.hhs.gov Received 4 December 2013 Revised 27 February 2014 Accepted 28 February 2014
Objective To review the available evidence evaluating the chemicals in refill solutions, cartridges, aerosols and environmental emissions of electronic cigarettes (e-cigarettes).
Methods Systematic literature searches were conducted to identify research related to e-cigarettes and chemistry using 5 reference databases and 11 search terms....